wHiPi. blog: GLP-1 Hair Shedding After 35, featuring Boost – Crown Whip Scalp Tonic and Detox – Crown Whip Scalp Pre-Wash

GLP-1 Hair Shedding After 35: What Your Trichologist Wants You to Know

I'm Kayla McNeill—licensed cosmetologist, trichologist, and hair loss specialist, and the founder of wHiPi. I'm also a millennial in midlife, which means I hear this question from the wHiPi. community and from our customers, in my inbox, and sometimes in my own bathroom mirror: "I'm finally losing the weight. So why am I also losing my hair?"

If you started a GLP-1 medication—semaglutide, tirzepatide, or another drug in this class—and a few months later your shower drain started telling a different story, you are not imagining it. And you are not alone. The shedding many women notice is often telogen effluvium, a temporary shift in the hair cycle after a major change in the body. Rapid weight loss is a well-documented trigger. Perimenopause can stack another one on top of it.

What this shedding usually is (and isn't)

Your hair does not grow in a straight line. Follicles cycle through growth (anagen), a brief transition, and a resting phase (telogen) before a strand sheds and a new one begins. The American Academy of Dermatology notes that shedding 50 to 100 hairs a day is normal. In telogen effluvium, a physiologic stressor—including losing 20 pounds or more—pushes a larger share of follicles into the resting phase at once. Most people notice the extra shedding a few months after the trigger. As the body readjusts, hair typically regains its normal fullness within six to nine months.

That delay is why this feels so confusing. The medication is working. The scale is moving. Then your part looks wider and your ponytail feels thinner. It can look like the medication "attacked" your hair. More often, your follicles are responding to the speed and scale of the change in your body. Shedding is also not the same as every kind of hair loss. If your loss is patchy, you have scalp pain, itching, or burning, or the shedding is not settling, please see a dermatologist or a hair-loss specialist.

What the current research actually shows

In the FDA-reviewed adult trials of Wegovy (semaglutide 2.4 mg weekly), hair loss was reported in 3% of people on the medication versus 1% on placebo.

For Zepbound (tirzepatide), hair loss is listed among the more commonly reported adverse reactions. In a pool of two weight-reduction trials, it was reported in about 4% to 5% of people on Zepbound versus 1% on placebo. The prescribing information is clear on two points that matter for women: the hair-loss reactions were associated with weight reduction, and they were reported much more often in female patients (7.1%) than in male patients (0.5%). Placebo rates were 1.3% in women and 0% in men.

A 2026 systematic review reached a similar conclusion: women appear disproportionately affected, telogen effluvium is a leading pattern, and rapid weight loss is a likely contributor. A large 2026 real-world study then compared 547,993 adults on GLP-1 receptor agonists with the same number of matched controls. At 12 months, GLP-1 use was associated with higher odds of telogen effluvium (adjusted odds ratio 1.76), androgenetic alopecia (1.64), and overall nonscarring hair loss (1.40). That is an association, not proof of a direct drug-to-follicle effect.

A 2026 scoping review in the Journal of Investigative Dermatology found that telogen effluvium was reported most often 10 to 18 weeks after starting therapy or increasing the dose. In cases with a recorded outcome, partial or complete regrowth was observed in about 40% to 50% after dose reduction, discontinuation, or supportive care. I treat that as a signal, not a promise, because the evidence base is still limited.

The honest takeaway: this is a real, documented pattern. It is not inevitable. And for many women, it is a chapter—not the whole book.

Why perimenopause can make it feel louder

Perimenopause can last years. Estrogen, which helps keep more hairs in the growth phase, begins to fluctuate and eventually decline. A 2025 review in Maturitas describes changes in density, caliber, and texture, and notes that telogen effluvium and female-pattern hair loss are reported more often around and after menopause. An earlier British Journal of Dermatology review found that menopausal status influenced growth rate, the percentage of hairs in anagen, and diameter—especially at the frontal scalp—and that the combined impact was most notable in the mid-forties.

So if you are 35-plus, on a GLP-1, and already noticing a change in density or caliber, you may be looking at two stressors landing in the same scalp. Weight-management specialists have made the same clinical observation: this concern tends to come up in perimenopausal and postmenopausal women who have had substantial weight loss. That overlap does not mean you did anything wrong. It means your hair is living in a real body, in a real season.

What I want you to do next

First, talk with the clinician who prescribed your medication before you change a dose or stop a therapy. Your hair matters. So does the reason you started treatment. Then get practical about the basics that support a shedding season:

  • Nutrition still counts when your appetite is quieter. A smaller appetite can make protein, iron, and other micronutrients harder to maintain. Ask your care team whether labs—such as iron/ferritin, thyroid, and vitamin D, as they deem appropriate—make sense for you.
  • Be gentle with hair already in a fragile phase. Ease up on tight styles, harsh scrubbing, and high heat. You cannot drag a resting hair back into growth, but you can avoid adding breakage.
  • Track, don't spiral. A monthly photo in the same light, same part, and same place is more useful than checking your brush every hour.
  • Know when to get a workup. If shedding is sudden, patchy, accompanied by scalp symptoms, or still going strong past the typical window, see a dermatologist or trichologist. Telogen effluvium and female-pattern thinning are not the same problem, and some women have both.

How I take care of my scalp

I treat my scalp like skin. That is not a shedding-season habit. It is my regular routine.

I use Crown Whip at least three times a week — not every day, and not only when I am worried about my hair. The step I will not skip is Boost – Crown Whip Scalp Tonic. After I cleanse and condition, a few drops go onto my scalp. I massage them in with my fingertips, and I leave it in. Boost is huge in my routine. It is the leave-in I come back to, week after week, because I want the skin my hair grows from to be cared for the same way I would care for the skin on my face.

Detox – Crown Whip Scalp Pre-Wash is my pre-wash. On wash day, I massage it into a dry scalp before I shampoo, so buildup has a chance to loosen before I cleanse.

A few things I come back to, whether my hair is in a quiet season or a shedding one:

  • Pre-wash the buildup. Product, oil, and hard-water residue sit on the scalp the same way they sit on skin. A pre-wash with Detox, then a thorough cleanse, gives that skin a reset before anything else goes on.
  • Cleanse the scalp; condition the lengths. I keep conditioner on the hair, not piled on the scalp, then I follow with Boost as my leave-in scalp step.
  • Massage, don't scratch. Fingertips, light pressure, a minute or two. It helps the tonic meet the scalp, and it is kinder than nails or a harsh scrub.
  • Be consistent, not daily. At least three times a week is the rhythm I keep. A routine you can actually keep does more for the scalp than a product you only reach for when you panic.
  • Protect the scalp you are trying to care for. Ease up on high heat at the roots, cover up in strong sun, and give tight styles a rest. The scalp is skin. It does better when it is not stressed on every side.

These are not a treatment for medication-related shedding, and they will not pull a resting hair back into growth. They are how I take care of my scalp, in every season. Scalp first. Then the hair has something good to grow from.

A note from me to you

I lost my hair once, and I grew it back. I will never make light of what it feels like to watch it leave.

If you are doing the hard work of taking care of your health, your hair can have a plan too. Give your follicles time, and get the right eyes on your scalp if something feels off. A shedding season is information, not a verdict. You are allowed to want your health and your hair.

If this helped you put words to what you are seeing, share it with a friend who might need the real explanation. And if you have a question for a future post, send it to hello@whipico.com—I am listening.

This article is for education, not medical advice. It is not a diagnosis, and it is not a recommendation to start, stop, or change any medication. Please talk with your healthcare provider about your own treatment plan.

Sources

  1. American Academy of Dermatology, "Do you have hair loss or hair shedding?"
  2. Wegovy (semaglutide) Prescribing Information, U.S. FDA
  3. Zepbound (tirzepatide) U.S. Prescribing Information, Eli Lilly
  4. Gupta AK, Teasell EM, Economopoulos V, Mirmirani P. "GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling." 2026.
  5. Akiska YM, et al. "Increased Incidence and Risk of Hair Loss with Glucagon-like Peptide 1 Receptor Agonists: A Real-World Multicentre Cohort Study." EMJ Dermatology, 2026.
  6. "Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies." Journal of Investigative Dermatology, 2026.
  7. "Menopause and hair loss in women: Exploring the hormonal transition." Maturitas, 2025.
  8. Mirmirani P. "Hormonal changes in menopause: do they contribute to a 'midlife hair crisis' in women?" British Journal of Dermatology, 2011.
  9. Medscape, "Navigating GLP-1 Hair Loss With Your Patients," 2026
Back to blog

Leave a comment